Market Overview:
The global raloxifene hydrochloride tablets market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of osteoporosis and breast cancer, rising geriatric population, and growing demand for generic drugs. By type, the global raloxifene hydrochloride tablets market is segmented into original drugs and generic drugs. The original drug segment is expected to account for a larger share of the global raloxifene hydrochloride tablets market in 2018. However, the generic drug segment is projected to grow at a higher CAGR during the forecast period from 2018 to 2030. By application, hospital pharmacies accounted for the largest share of the global raloxifene hydrochloride tablets market in 2017; however, retail pharmacies are projected to grow at a higher CAGR duringthe forecast period from 2018to2030.
Product Definition:
Raloxifene Hydrochloride Tablets are used to prevent and treat osteoporosis in women who have gone through menopause.
Original Drugs:
The global original drugs market size was valued at USD 4.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of osteoporosis globally, as well as the growing geriatric population base, which are highly susceptible to this disease, will serve this market as a high impact rendering driver.
Generic Drugs:
A generic drug is a pharmaceutical product that has an active ingredient similar to that of a branded drug. The only difference between the two is the price; whereas, the cost of production and distribution are shared by all brands as well as generics.
The demand for generic drugs has increased in recent years owing to their cost effectiveness and extensive use in various therapeutic areas such as oncology, dermatology, cardiology & hypertension.
Application Insights:
The global raloxifene hydrochloride tablets market is categorized on the basis of application into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment is anticipated to expand at a CAGR of XX% over the forecast period owing to various benefits offered such as convenience and flexibility in scheduling drug orders, ease of payment processing through third-party processors like PayPal, etc. Additionally, an increase in healthcare awareness among individuals has led them to prefer purchasing medicines from online sources due to their lower prices as compared to brick-and-mortar stores or hospitals. This trend is expected drive growth during the forecast period.
Hospital pharmacies accounted for a major share owing to high usage rates for chronic conditions that require long term treatment such as osteoarthritis pain.
Regional Analysis:
North America was the largest regional market in 2017 owing to high awareness levels and availability of a large patient pool. The region is expected to maintain its dominance over the forecast period due to increasing Raloxifene Hydrochloride Tablets sales online and offline. Moreover, presence of key manufacturers such as Pfizer Inc.; Ortho-McNeil Pharmaceutical; Alkermes plc; Cipla Inc.; Mylan N.V.; Actavis Plc; Teva Pharmaceuticals USA, Inc., will also help maintain this dominance during the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions with a CAGR 6% higher than North America during the forecast period owing to rising geriatric population base coupled with improving economic status in emerging countries such as China & India & Bangladesh & Pakistan among others).
Growth Factors:
- Increasing prevalence of osteoporosis and other bone disorders: The global Raloxifene Hydrochloride Tablets market is expected to benefit from the increasing prevalence of osteoporosis and other bone disorders. This is primarily owing to the efficacy of Raloxifene Hydrochloride Tablets in preventing and treating such conditions.
- Rising awareness about the benefits of Raloxifene Hydrochloride Tablets: There is a growing awareness among consumers about the benefits of using Raloxifene Hydrochloride Tablets for preventing and treating various bone-related disorders. This is likely to boost demand for these tablets in the coming years.
- Growing geriatric population: The global geriatric population is on the rise, which is expected to drive demand for Raloxifene Hydrochloride Tablets in the near future. These tablets are particularly beneficial for older adults as they help prevent age-related bone loss and fractures.
Scope Of The Report
Report Attributes
Report Details
Report Title
Raloxifene Hydrochloride Tablets Market Research Report
By Type
Original Drugs, Generic Drugs
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Eli Lilly, Apotex Corporation, Teva Pharmaceutical, Jiangsu Hengrui Medicine, Aurobindo Pharma, Glenmark Pharmaceuticals, Sciegen Pharmaceuticals, Prasco Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Raloxifene Hydrochloride Tablets Market Report Segments:
The global Raloxifene Hydrochloride Tablets market is segmented on the basis of:
Types
Original Drugs, Generic Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Apotex Corporation
- Teva Pharmaceutical
- Jiangsu Hengrui Medicine
- Aurobindo Pharma
- Glenmark Pharmaceuticals
- Sciegen Pharmaceuticals
- Prasco Laboratories
Highlights of The Raloxifene Hydrochloride Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Original Drugs
- Generic Drugs
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Raloxifene Hydrochloride Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Raloxifene hydrochloride tablets are a medication used to treat osteoporosis. Raloxifene hydrochloride tablets work by reducing the amount of bone loss in the body.
Some of the major players in the raloxifene hydrochloride tablets market are Eli Lilly, Apotex Corporation, Teva Pharmaceutical, Jiangsu Hengrui Medicine, Aurobindo Pharma, Glenmark Pharmaceuticals, Sciegen Pharmaceuticals, Prasco Laboratories.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Raloxifene Hydrochloride Tablets Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Raloxifene Hydrochloride Tablets Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Raloxifene Hydrochloride Tablets Market - Supply Chain
4.5. Global Raloxifene Hydrochloride Tablets Market Forecast
4.5.1. Raloxifene Hydrochloride Tablets Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Raloxifene Hydrochloride Tablets Market Size (000 Units) and Y-o-Y Growth
4.5.3. Raloxifene Hydrochloride Tablets Market Absolute $ Opportunity
5. Global Raloxifene Hydrochloride Tablets Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Type
5.3.1. Original Drugs
5.3.2. Generic Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Raloxifene Hydrochloride Tablets Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Raloxifene Hydrochloride Tablets Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Raloxifene Hydrochloride Tablets Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Raloxifene Hydrochloride Tablets Demand Share Forecast, 2019-2026
9. North America Raloxifene Hydrochloride Tablets Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Type
9.7.1. Original Drugs
9.7.2. Generic Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Raloxifene Hydrochloride Tablets Demand Share Forecast, 2019-2026
10. Latin America Raloxifene Hydrochloride Tablets Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Type
10.7.1. Original Drugs
10.7.2. Generic Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Raloxifene Hydrochloride Tablets Demand Share Forecast, 2019-2026
11. Europe Raloxifene Hydrochloride Tablets Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Type
11.7.1. Original Drugs
11.7.2. Generic Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Raloxifene Hydrochloride Tablets Demand Share, 2019-2026
12. Asia Pacific Raloxifene Hydrochloride Tablets Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Type
12.7.1. Original Drugs
12.7.2. Generic Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Raloxifene Hydrochloride Tablets Demand Share, 2019-2026
13. Middle East & Africa Raloxifene Hydrochloride Tablets Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Raloxifene Hydrochloride Tablets Market Size and Volume Forecast by Type
13.7.1. Original Drugs
13.7.2. Generic Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Raloxifene Hydrochloride Tablets Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Raloxifene Hydrochloride Tablets Market: Market Share Analysis
14.2. Raloxifene Hydrochloride Tablets Distributors and Customers
14.3. Raloxifene Hydrochloride Tablets Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Eli Lilly
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Apotex Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Teva Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jiangsu Hengrui Medicine
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Aurobindo Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Glenmark Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sciegen Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Prasco Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
